What is the clinical significance of left atrial reservoir strain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Significance of Left Atrial Reservoir Strain

Left atrial reservoir strain (LASr) <30% indicates significant impairment of left atrial function and predicts poor outcomes across multiple cardiovascular conditions, serving as a powerful prognostic marker that often outperforms traditional volume-based measurements. 1

Prognostic Value and Risk Stratification

LASr functions as an integrated marker of left atrial-left ventricular interaction and provides independent prognostic information beyond conventional parameters:

Mortality and Major Adverse Events

  • Reduced LASr independently predicts all-cause mortality in the general population, providing incremental value beyond clinical risk factors, LV mass, and LVEF 2
  • In acute coronary syndrome, higher LASr associates with lower risk of major adverse cardiovascular events (MACE), with each 1% increase conferring a 6% risk reduction (HR 0.94 per 1% increase) 3
  • LASr <18.8% independently predicts death and heart failure after myocardial infarction, incremental to LVEF, global longitudinal strain, microvascular obstruction, and infarct size 2

Heart Failure Risk

  • LASr predicts incident heart failure 8 years before symptom onset, independent of clinical risk factors, LV mass, and natriuretic peptides 2
  • In patients hospitalized with acute decompensated HFpEF, persistently impaired or worsening LASr during one-year follow-up associates with rehospitalization and cardiovascular death 4
  • After mitral transcatheter edge-to-edge repair, early LASr improvement (≥15% relative increase) independently predicts lower risk of death and heart failure hospitalization 5

Diagnostic Applications

Diastolic Dysfunction and Elevated Filling Pressures

LASr <18% reliably identifies elevated LV filling pressure (PCWP ≥15 mmHg), particularly when LVEF <50% 2. This threshold is more sensitive than LA volume index for detecting elevated filling pressures, even when LAVI remains normal during sinus rhythm 2.

The diagnostic thresholds for diastolic dysfunction severity are:

  • LASr <35%: Separates normal from Grade 1-3 diastolic dysfunction
  • LASr <24%: Distinguishes Grade 1 from Grade 2-3
  • LASr <19%: Identifies Grade 3 from Grade 1-2 2

HFpEF Diagnosis

Reduced LASr, combined with enlarged LAVI, impaired global longitudinal strain, and LV hypertrophy, supports HFpEF diagnosis 2. When traditional diastolic dysfunction parameters yield indeterminate results, LASr <18% can replace missing parameters in the algorithm for estimating LV filling pressure 2.

Atrial Fibrillation Risk and Burden

  • **LASr <21.5% predicts high AF burden** (>10.49% of time in AF) with 75% sensitivity and 83% specificity 6
  • Reduced LASr predicts new-onset AF after coronary artery bypass surgery 2
  • In hypertrophic cardiomyopathy, reduced LASr predicts incident AF 2

Disease-Specific Significance

Cardiac Amyloidosis

Poor or absent LASr with preserved sinus rhythm (atrial electromechanical dissociation) is a distinct feature and poor prognosticator in cardiac amyloidosis 2. Reduced LASr associates with histopathologically confirmed atrial natriuretic peptide-amyloid deposition, and this deposition correlates with increased heart failure hospitalization 7.

Hypertrophic Cardiomyopathy

Reduced LASr identifies patients at risk for AF and adverse outcomes, with LA diameter incorporated into sudden cardiac death risk scoring 2. Impaired LASr occurs even in preclinical HCM (positive genotype without LV hypertrophy) 2.

Ischemic Heart Disease

In acute MI patients, LASr assessed within 48 hours predicts death and heart failure, providing incremental value beyond LAVI 2. LA functional indices correlate more strongly with LV filling pressure than LA volume after acute MI, as dilatation reflects chronic processes 2.

Technical Considerations and Measurement

Critical Measurement Points

Measurement timing depends on rhythm 1:

  • Sinus rhythm: Reference point at P-wave onset
  • Atrial fibrillation: Reference point at R-wave of QRS complex

Normal Values

Normal LASr values vary by reference point 1:

  • QRS onset reference: 46.8 ± 7.7%
  • P-wave onset reference: 35.6 ± 7.9%

Common Pitfalls

  • The interatrial septum poses technical challenges due to poor visualization and influence from right atrial pressure
  • LA appendage can compromise speckle tracking in 2-chamber views
  • Structural abnormalities (atrial septal aneurysm, atrial septal defect) influence absolute strain values
  • Vendor-dependent software differences affect normative values
  • Most studies focus on 4-chamber view; comprehensive assessment requires biplane or triplane imaging 1

Clinical Implementation

The lateral LA wall strain provides the most reliable measurement, as it is not constrained by other cardiac chambers and serves as the best surrogate for atrial wall fibrosis detected by cardiac MRI 1.

For risk stratification, serial LASr assessment provides superior prognostic information compared to single measurements, particularly in heart failure populations where improvement or persistent impairment guides therapeutic optimization 5, 4.

The most recent 2025 European consensus 2 emphasizes that LASr should be incorporated into comprehensive cardiac assessment, particularly for diastolic dysfunction evaluation, HFpEF diagnosis, and prognostication across cardiovascular diseases where it consistently demonstrates incremental value beyond traditional volumetric and functional parameters.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.